TopoTarget initiates patient recruitment in lymphoma trial
The trial will enroll approximately 120 patients. TopoTarget has a special protocol assessment agreement with the FDA where the design of the study has been agreed. Furthermore a
Sun Pharmaceutical Industries has agreed to purchase India-based Innovcare Lifesciences in a deal valued at approximately Rs2.71bn ($28.7m).